Investigates the effects of haze on water-soluble arsenic in urban environments, indicating a rise in health risks.
Atmospheric arsenic (As) poses significant health threats in heavily polluted urban environments. However, the size-resolved distribution of water-soluble arsenic (WSAs) in atmospheric particulate matter, as well as the size-dependent variation in As concentration and solubility under contrasting haze and non-haze conditions, remains insufficiently characterized. This study investigated the concentration, size distribution, water solubility, sources, and health risks of particulate-bound As and WSAs in Beijing from April 2014 to February 2015. The annual mean PM0.1–18 concentration was 136.96 ± 54.21 μg·m−3, with significantly higher levels observed during haze episodes (179.61 ± 41.71 μg·m−3) compared to non-haze periods (118.00 ± 49.42 μg·m−3). The annual mean concentration of As was 6.42 ± 3.69 ng·m−3, exceeding both WHO guidelines and Chinese standards during haze periods, while WSAs averaged 4.54 ± 2.50 ng·m−3. Distinct size distribution patterns were observed: As displayed, a unimodal fine-mode peak (0.32–0.56 μm) was observed during haze periods and a bimodal distribution during non-haze conditions, whereas WSAs followed comparable size-dependent behavior, reflecting shifts in dominant emission sources and atmospheric processes. The average WSAs/As ratio (0.72 ± 0.07) indicated high As solubility and strong associations with secondary species and anthropogenic emissions. Size-resolved analysis revealed that As was preferentially enriched in fine particles, particularly during haze episodes, whereas coarse particles became more prominent under non-haze conditions, especially in spring, likely driven by regional dust transport and its interactions with anthropogenic emissions. Deposition modeling based on the ICRP framework showed that As and WSAs were primarily deposited in the headway (HA: 0.68 and 0.32 ng·h−1, respectively), followed by the alveolar region (AR: 0.29 and 0.20 ng·h−1, respectively). Fine particles enhanced deposition in deeper lung regions during haze episodes, whereas coarse particles contributed more to upper airway deposition under non-haze conditions. Although inhalation carcinogenic risks remained within acceptable limits (10−6–10−4), risks were 1.60 times higher during haze periods, with adults bearing the greatest exposure burden. These findings demonstrate that haze conditions substantially alter the size distribution, solubility, and health risks of atmospheric arsenic, and provide a scientific basis for developing size-resolved and haze-targeted heavy metal monitoring strategies in urban environments subject to significant anthropogenic pollution.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: